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Abstract
Background: In network meta-analyses, several treatments can be compared by connecting evidence from clinical
trials that have investigated two or more treatments. The resulting trial network allows estimating the relative eﬀects
of all pairs of treatments taking indirect evidence into account. For a valid analysis of the network, consistent
information from diﬀerent pathways is assumed. Consistency can be checked by contrasting eﬀect estimates from
direct comparisons with the evidence of the remaining network. Unfortunately, one deviating direct comparison may
have side eﬀects on the network estimates of others, thus producing hot spots of inconsistency.
Methods: We provide a tool, the net heat plot, to render transparent which direct comparisons drive each network
estimate and to display hot spots of inconsistency: this permits singling out which of the suspicious direct
comparisons are suﬃcient to explain the presence of inconsistency. We base our methods on ﬁxed-eﬀects models.
For disclosure of potential drivers, the plot comprises the contribution of each direct estimate to network estimates
resulting from regression diagnostics. In combination, we show heat colors corresponding to the change in
agreement between direct and indirect estimate when relaxing the assumption of consistency for one direct
comparison. A clustering procedure is applied to the heat matrix in order to ﬁnd hot spots of inconsistency.
Results: The method is shown to work with several examples, which are constructed by perturbing the eﬀect of
single study designs, and with two published network meta-analyses. Once the possible sources of inconsistencies are
identiﬁed, our method also reveals which network estimates they aﬀect.
Conclusion: Our proposal is seen to be useful for identifying sources of inconsistencies in the network together with
the interrelatedness of eﬀect estimates. It opens the way for a further analysis based on subject matter considerations.
Keywords: Network meta-analysis, Inconsistency, Cochran’s Q, Hat matrix
Background
Evidence from various treatment comparisons in diﬀer-
ent randomized trials can be combined by a network
meta-analysis. This method not only aggregates evi-
dence from direct comparisons, but also involves indirect
comparisons, i.e. relative eﬀect inferences for previously
observed or not observed contrasts. References [1-4] give
an overview of the recent methodological development.
The validity of a network meta-analysis and, in particular,
that of the indirect comparisons depends on a consis-
tent network of treatment eﬀects. However, there might
be speciﬁc treatment eﬀects in the network that lead to
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inconsistency, e.g. due to being based on studies with
divergent patient or trial characteristics [5,6] or due to bias
[7]. Perturbed treatment eﬀects can strongly aﬀect other
network estimates, which induces further inconsistency
between direct and indirect estimates. This calls for tools
that can identify the ﬂow of evidence in the network, i.e.
that can highlight direct comparisons that strongly drive
other treatment eﬀect estimates and hot spots of network
inconsistency.
In this context, inconsistency means disagreement
between direct and indirect evidence that can occur in
addition to heterogeneity between studies with the same
treatment arms. A network meta-analysis can be visual-
ized by a graph, whereby the set of nodes corresponds to
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the considered treatments and the edges display the treat-
ment comparisons of all included trials. If correspond-
ing treatment eﬀect estimates of various connections, or
so called paths, diﬀer between two treatments, there is
inconsistency. Since the start and end point for diﬀerent
alternative network paths are the same, inconsistency can
only be detected in such network loops [8,9]. It is not pos-
sible to trace inconsistency back to a single comparison in
a network that only includes one loop, but comparisons
that are included in several loops may be identiﬁable as a
unique source for a hot spot of inconsistency.
In the following, we therefore provide methods for iden-
tifying such hot spots, which might consist of loops,
parts of loops or even just single comparisons. We also
investigate the inﬂuence of individual comparisons on the
network estimates that might drive further perturbation
and invalid network estimates due to the network design.
Diﬀerent approaches to assess inconsistency have been
discussed. The series of Technical Support Documents
produced by the NICE Decision Support Unit [10] pro-
vides a detailed review of methods on this topic. The
oldest method to assess inconsistency is to examine it in
three-treatment loops [11]. For example, Cipriani et al.
[12] apply it to every three-treatment loop in the net-
work. While including larger loops as well, Salanti et al.
[6] systematically repeat the method for every loop in the
network. Another method to assess inconsistency is to
set up a mixed model with a sparse covariance structure
that allows for one extra variance component to capture
inconsistency; this was performed in a classical likelihood
framework [8] and in a Bayesian framework [9,13].
Finally, consistency can be assessed by comparing a
model that satisﬁes only some consistency restrictions
(or no restrictions at all) with the consistency model.
The node-splitting method [14] extends the consistency
model by only one parameter that captures the diﬀer-
ence between a contrast, e.g. treatment A versus treat-
ment B, that is assessed in all direct comparisons and
the same contrast assumed to be valid from the indi-
rect evidence. Unfortunately, the deﬁnition of the indirect
evidence is not quite clear for multi-armed studies, and
the node-splitting methods were recognized as depend-
ing on the choice of reference treatment in multi-armed
studies [15,16]. Recently, Higgins et al. [15] and White
et al. [16] have set up a modeling paradigm where studies
are distinguished by design, i.e. by the full set of treat-
ments compared. In this case, the eﬀect of a contrast, e.g.
between treatment A and treatment B, may diﬀer in the
full inconsistency model depending on being estimated
in two-armed studies or e.g. in three-armed studies con-
taining additionally treatment C, or treatment D. In their
model, inconsistency is no longer a violation of some
equations that reﬂect loops, but rather model parameters
reﬂecting design-by-treatment interactions. Lu et al. [9]
and White et al. [16] have used the term inconsistency
degrees of freedom for the diﬀerence in the number of
parameters between the full inconsistency model and the
consistency model, but Lu et al. [9] deﬁned them with-
out distinguishing direct evidence from two-armed and
multi-armed studies.
Lu and Ades [9] gave preference to a Bayesian approach
and favored random-eﬀects models that include inconsis-
tency factors as random eﬀects. Senn et al. [17] cautioned
against random-eﬀects analysis and pointed out (as did
[18]) that in ﬁxed-eﬀects models with variances assumed
to be known, a Cochran-type chi-squared statistic results
for the overall heterogeneity in the network. Caldwell et al.
[19] proposed a chi-squared statistic for testing the con-
sistency of independent network paths between one pair
of treatments. White et al. [16] proposed a global Wald
chi-squared test for all design-by-treatment interaction
parameters (treated as ﬁxed eﬀects), applied in a model
with random eﬀects for heterogeneity within designs that
is ﬁtted via restricted maximum likelihood method. This
test may lack power by implicitly attributing part of the
inconsistency to heterogeneity.
In this paper, we will deﬁne another global chi-squared
test for inconsistency that results by comparing a ﬁxed-
eﬀects model for inconsistency with a consistency model.
It will emerge as a part of the decomposition of Cochran’s
Q statistic into components accounting for heterogeneity
among studies sharing the same design and inconsistency.
Once inconsistency has been assessed globally, means
are needed to ﬁnd its sources. Senn et al. [17] inspected
the squared Pearson residuals at the study level, which
sum up to the overall Q chi-squared statistic. The
design-by-treatment interaction parameters introduced
by [15,16] may be used to spot inconsistency. Unfortu-
nately, the deﬁnition of these parameters relies on the
ordering of treatments. More generally, all regression
diagnostic methods (see [20]) can be applied. References
[21,22] have discussed this for classical meta-analysis and
[23] for network meta-analysis. There are some attempts
to visualize network meta-analysis for assessing hetero-
geneity, including inconsistency [6,9,14,17,23,24]. None of
these have met with general acceptance as yet, and they
do not address the needs as well as the forest plot does
in classical meta-analysis, which simultaneously discloses
each study’s weight and deviation from the pooled esti-
mate. Notably, for this purpose, the Galbraith plot [25],
although far less commonly used, is even better suited.
In the following, we systematically develop a graphi-
cal tool for highlighting hot spots of inconsistency by
considering the detailed change in inconsistency when
detaching the eﬀect of studies with the same treatment
arms. Furthermore, we identify drivers for the network
estimates. Highlighting of inconsistency will providemore
information than just singling out inconsistent loops. We
Krahn et al. BMCMedical ResearchMethodology 2013, 13:35 Page 3 of 18
http://www.biomedcentral.com/1471-2288/13/35
provide a matrix display that summarizes network drivers
and inconsistency in two dimensions, such that it may
be possible to trace inconsistency back to single deviat-
ing direct comparisons. Naturally, it is diﬃcult to dis-
play detailed network properties in just two dimensions,
but we propose a clustering approach that automatically
groups comparisons for highlighting hot spots.
Section “Methods” provides a detailed description of the
diﬀerent building blocks of our proposal: We present a
ﬁxed-eﬀects model for network meta-analyses within the
framework of general linear models with known variances
in Section “Parameterization and two-stage analysis of a
ﬁxed-eﬀects model in network meta-analysis”. Based on
this model, we discuss the resulting hat matrix in Section
“Identifying drivers via the hat matrix”, which we use as
an instrument for identifying drivers. We suggest using a
chi-squared statistic for the heterogeneity in the network,
which we decompose into a test statistic for the incon-
sistency and a test statistic for the heterogeneity within
groups of studies, classiﬁed according to which treatments
are involved. A graphical tool that visualizes the network
drivers and inconsistency hot spots is given in Section
“Identifying hot spots of inconsistency”. Speciﬁcally, we
use the inconsistency information along with detach-
ing of single component meta-analyses to locate incon-
sistency hot spots. All the steps in Section “Methods”
are illustrated using artiﬁcial examples. Section “Results”
then provides results for two published network anal-
yses. Finally, we discuss our methods and results in
Section “Discussion”, and we provide concluding remarks
in Section “Conclusions”.
Methods
In the following, we provide a ﬁxed-eﬀects model for
network meta-analyses, on which we base our fur-
ther analysis. We present tools to identify hot spots of
inconsistency in the network and drivers with a high
impact on network estimates. Using these two tools, we
provide a graphical display to locate potential sources
of inconsistency.
Parameterization and two-stage analysis of a ﬁxed-eﬀects
model in network meta-analysis
We consider a network meta-analysis with T + 1 treat-
ments A0, . . . ,AT , under which A0 represents a reference
treatment. A total of S studies compares these treat-
ments, such that a graphical representation of the com-
parison network with treatments as nodes and edges
linking treatments directly compared in some studies cre-
ates a connected graph (see e.g. Figure 1a). We summarize
all studies s (s = 1, . . . , S) in the set S , classify each
study by the number of included treatments Ns and by a
design index d = 1, . . . ,D according to which treatments
are respectively involved (see [15,16,23] for a similar
approach). We deﬁne Sd as the subset of studies with the
same design d that includes Nd diﬀerent treatments.
For a ﬁxed-eﬀects analysis, this network can be written
in matrix notation as the following general linear model
with heteroscedastic sampling variances:
Y = Xθnet + . (1)
Y is a vector of observed treatment eﬀects of all S stud-
ies, e.g. log odds ratios for a binary outcome and the
design matrix X with T columns contains the structure
of the network at the study level. For all studies of one
design, we choose the same reference treatment. Assum-
ing a consistent network, we estimate the vector of basic
parameters θnet (in terminology of [9]) corresponding to
the treatment eﬀects of all T comparisons to the reference
treatment. By considering linear combinations of them,
we can then infer all other eﬀects of the network. The vec-
tor  comprises all error terms of the model with E() = 0
and known covariance matrix V, which has a diagonal
form. The length of vector Y and  as well as the number
of rows of X and V depend on the number and design of
the included studies. Each two-armed study provides one
entry to Y, one entry to the diagonal of V, and one row to
X. We deal with the case of multi-armed studies separately
in Section “Multi-armed studies”.
For exemplifying the model components, we con-
sider a simple example of a network meta-analysis with
three treatments A0,A1,A2 (T = 2) and four observed
studies (S = 4): two studies (s = 1, 2) for comparison
A1 versus A0 (d = 1), one study (s = 3) for com-
parison A2 versus A0 (d = 2), and one study (s = 4)
for comparison A2 versus A1 (d = 3). Then the basic
parameters are θnet0:1 and θnet0:2 for the contrast of treat-
ment A1 versus A0 (d = 1, named 0:1) and the con-
trast of treatment A2 versus A0 (d = 2, named 0:2).
Under the consistency assumption, it follows that the
eﬀect θnet1:2 = θnet0:2 − θnet0:1 . Let Ys be the observed eﬀect and


















⎥⎥⎦ , V =
⎡
⎢⎢⎣
V1 0 0 0
0 V2 0 0
0 0 V3 0
0 0 0 V4
⎤
⎥⎥⎦ .
The vector of the basic parameters θnet can be esti-
mated in a classical frequentist manner by generalized
least squares as follows:
θˆnet = (X′V−1X)−1X′V−1Y , (2)
which is sometimes referred to as the Aitken estimator
[26].
This estimation can equivalently be performed in two
steps (as discussed in [18,23]). First, D meta-analyses
with inverse variance weighting summarization provide
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pooled estimates and their variances per study design.
Secondly, model (1) deals with the results of these compo-
nent meta-analyses just as with single study observations.

























Thus, evidence of all studies with the same treatment
arms (s ∈ Sd) is initially summarized, resulting in esti-
mated treatment eﬀects θˆdird and covariance matrices V dird
of so-called direct comparisons, since these comparisons
are actually observed. In the second stage of the estima-
tion, a linear model is ﬁtted to the eﬀect vector θˆdir :=
(θˆdir1 , . . . , θˆdirD )′ of all summarized direct comparisons:
θˆdir = Xaθnet + a (5)
with E(a) = 0 and Cov(a) =: Va. The covariance
matrix is given by Va := diag(V dir1 , . . . ,V dirD ) and Xa is the
compressed design matrix containing one set of rows for
each design. In the case of two-armed studies, the design
matrix Xa is formed by stacking one row over each of the











We distinguish each set of multi-armed studies sharing
the same set of treatments as a diﬀerent design. That
means that if we add a three-armed study for A2 versus
A1 versus A0 to the example above, we consider a further
design (d = 4).
Since the eﬀects observed in one multi-armed study
cannot be inconsistent, we use one design-speciﬁc treat-
ment as a study reference for each multi-armed study,
e.g. A0 in all studies comparing A2 versus A1 versus A0.
Then, a study with M + 1 arms adds to the vector Y of
model (1) a vector Ys of M treatment eﬀects for each
comparison to the reference. In our example we have the
vector Ys = (Y0:1,Y0:2)′ of comparison A1 versus A0 and
comparison A2 versus A0. Furthermore, the multi-armed
study gives M rows for X with the corresponding con-
trasts. Since pairwise treatment eﬀects of one study are
correlated, the multi-armed study adds a block Vs of size
M×M for the covariance matrixV of the sampling error 
(compare to [13,27]). In the case of multi-armed studies of
design d, a summarized treatment eﬀect θˆdird is a vector of
lengthMwith covariancematrixV dird of sizeM×M. These
summarizations can be calculated in accordance with the
equations (3,4) [28] and can be used as observations in
model (5). The design matrix Xa contains then M rows
for the corresponding design of the studies. This means in
the simple example above with four two-armed and one












Identifying drivers via the hat matrix
In linear models, the hat matrix contains the linear coeﬃ-
cients that present each predicted outcome as a function
of all observations. Its diagonal elements are known as
leverages. They summarize the importance of the respec-
tive observation for the whole estimation. Observations
with both high leverage and large residual are recognized
as being highly inﬂuential [29].
In the context of network meta-analyses and model (5),
the hat matrix is:
H := Xa(X′aV−1a Xa)−1X′aV−1a . (6)
Its rows are the linear coeﬃcients of θˆdird (d = 1, . . . ,D)
for the network estimate θˆnetd′ , where θˆnetd′ is the subvec-
tor of θˆnet corresponding with design d′. The coeﬃcients
are a generalization of the study weights in simple meta-






























-3 -7 10 -3 -10 -37 27 63
-7 -13 20 -7 -20 27 53 27
-3 -7 10 -3 -10 63 27 -37
-10 -20 30 -10 70 -10 -20 -10
-37 27 10 63 -10 -3 -7 -3
10 20 70 10 30 10 20 10
27 53 20 27 -20 -7 -13 -7
63 27 10 -37 -10 -3 -7 -3
Figure 1 Network design and hat matrix of an illustrative
network meta-analysis. In a), the network design of an illustrative
example is given: six treatments and eight diﬀerent observed designs
based on two-armed studies. The nodes correspond to the
treatments, and the edges show which treatments are directly
compared. The thickness of an edge represents the inverse standard
error (Vdird )
−1/2, which is equal one for all designs. In b), the resulting
hat matrix at the design level is given in percent, which indicates the
contribution of the direct estimate in design d (shown in the column)
to the network estimate in design d′ (shown in the row). In addition,
the absolute values of the matrix elements are visualized by the area
of the gray squares.
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between -1 and 1. While in simple meta-analyses the con-
tribution of a study (or weight of a study) to the pooled
estimate is proportional to the precision of the study,
in network meta-analyses the contribution of direct esti-
mates to a network estimate is a function not only of its
precisions, but also of the network structure. Depending
on the agreement of direct and indirect evidence, a large
absolute entry in H indicates a strong inﬂuence of the
respective direct estimate. Note that H is not necessarily
symmetric, and for multi-armed studies the choice of the
reference treatment aﬀects the corresponding coeﬃcients.
In network meta-analyses, the diagonal elements of H
have a special role. In a connected network, the trace ofH
equals T, the number of parameters of model (5). In fact,
each network estimate can be written as a weighted mean
of a direct estimate which is based on all comparisons
involving only the given two treatments and the indirect
estimate which is based on all other studies. The diagonal
element of H is identical to the weight of the direct esti-
mate in this presentation. Diﬀerent than in many regres-
sion applications, the oﬀ-diagonal elements of H deserve
special attention in network meta-analyses. The smaller
the diagonal element, the more weight is given to indirect
evidence. This is also discussed in [18]. The oﬀ-diagonals
indicate which study designs contribute in an essential
way to the indirect part of the network estimate.
As an illustration of the hat matrix, we use an example
of a network meta-analysis with six treatments (T = 5)
and eight diﬀerent observed designs (D = 8) based on
two-armed studies (Nd = 2 for all d = 1, . . . , 8). The cor-
responding network is shown in Figure 1a), where the
nodes correspond to the treatments and the edges show
which treatments are directly compared. The thickness of
an edge represents the inverse standard error (V dird )−1/2,
which is equal to one for all d in our example (Va = I8,
where I8 is the identitymatrix of size eight). For one design
there might, for example, be one study with V−1/2s = 1
or 100 studies with V−1/2s = 0.1. The resulting hat matrix
at the design level is given in percent in Figure 1b). In
addition, the absolute values of the matrix elements are
visualized by the area of the gray squares.
The diagonal squares indicate that the network esti-
mates are predominantly driven by their corresponding
direct estimates, all more than 50%. The diagonal squares
are the largest for the edges 1:6 and 3:4 that intercede
between the two triangles. Their direct estimates drive
70% of their network estimates. The smallest diagonal
squares are seen for the edges 1:3 and 4:6 (direct estimates
drive 53%), since the latter ones are paralleled by two inde-
pendent indirect paths and the former ones only by one.
Inspecting the oﬀ-diagonal squares, we learn that aside
from its direct estimates, the network estimates θnet1:2 and
θnet2:3 are driven by the other corresponding direct estimate
and then by θdir1:3 . Due to symmetry, the same holds for the
edges involved in the triangle {4:5, 5:6, 4:6}.
Identifying hot spots of inconsistency
Decomposition of Cochran’s Q
An important aspect in meta-analysis is to investigate sta-
tistical heterogeneity. In network meta-analysis inconsis-
tency arises as another aspect of heterogeneity. In a clas-
sical meta-analysis comparing two treatments, Cochran’s
Q [30] is a well-accepted tool for assessing heterogeneity
between studies, which is seen to be the sum of squared
Pearson residuals. We use the generalized Cochran’s Q
statistic for multivariate meta-analysis [27,31] in the con-
text of network meta-analyses:
Qnet := (Y − Xθˆnet)′V−1(Y − Xθˆnet). (7)
To examine the heterogeneity of the whole network in
more detail, particularly considering the inconsistency in
the model, we decompose the Qnet statistic into two parts
(similar to [32] who used a decomposition by study group
in the context of classical meta-analysis):
Qnet = Qhet + Qinc. (8)








(Ys − θˆdird )′V−1s (Ys − θˆdird ). (10)
The second is a between-designs Q statistic
Qinc := (θˆdir − Xaθˆnet)′V−1a (θˆdir − Xaθˆnet). (11)
The heterogeneity of the whole network can be assigned
to the heterogeneity between studies by Qhet, related to
each design d with Qhetd , and otherwise to the inconsis-
tency of the network by Qinc. Under the null hypothesis
for both homogeneity and consistency, all Q statistics
((7), (9), (10), (11)) are approximately chi-squared dis-
tributed with respective degrees of freedom given in
Table 1. Thereby, the degrees of freedom of the chi-
squared distribution corresponding to Qinc are identical
to those deﬁned in [16]. All Q statistics are independent
of the choice of design-speciﬁc reference treatment.
For example, for the network design in Figure 1a)
we assume inconsistent treatment eﬀects by (θˆdir1:2 , θˆdir1:3 ,
θˆdir1:6 , . . . , θˆdir5:6 )′ = (5, 0, 0, . . . , 0)′, where each component
meta-analysis corresponds to one study. The perturbation
eﬀect of ﬁve means that the contrast diﬀers by ﬁve stan-
dard errors of a direct eﬀect estimate. This may be a lot
if the precision of component meta-analysis is small. This
eﬀect was chosen here in order to achieve a reasonable
power for illustration purposes.
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Table 1 The network Q statistics and the degrees of freedom of their corresponding chi-squared distribution
Null hypothesis Q statistic Degrees of freedom
Homogeneity in the whole network Qnet dfQnet :=
(∑
s∈S (Ns − 1)
)− T
Homogeneity within designs Qhet dfQhet :=
∑D
d=1 dfQhetd
Homogeneity within design d Qhetd dfQhetd
:=
(∑
s∈Sd (Ns − 1)
)
− Nd + 1
Consistency between designs Qinc dfQinc :=
(∑D
d=1 (Nd − 1)
)
− T
Consistency between designs after Qinc
(d) dfQinc(d)
:= dfQinc − Nd + 1
detaching the eﬀect of design d
In a network with T + 1 treatments and a set of studiesS , d = 1, . . . ,D designs are observed. The set of studies with design d is given bySd . The numbers of
treatments in study s and in design d are given by Ns and Nd respectively.
In real applications, the power may be small [33] and
a failure to detect inconsistency does not automatically
imply consistency. Note, however, that a deviating eﬀect
cannot be absorbed into a heterogeneity variance com-
ponent, other than in random-eﬀects models. Depending
on the number of studies that inform a design, a single
deviating study may inﬂate either Qinc or Qhet. That is
why inconsistency and heterogeneity must be considered
jointly.
As network estimates, we obtain in the example (θˆnet1:2 ,
θˆnet1:3 , θˆnet1:6 , θˆnet2:3 , θˆnet3:4 , θˆnet4:5 , θˆnet4:6 , θˆnet5:6 )′ = (3.167, 1.333, 0.500,−1.834,−0.500,−0.166,−0.333,−0.167)′. With this, an
inconsistency statistic Qinc = 3.36+ 1.78+ 0.25+ 3.36+
0.25+0.03+0.11+0.03 = 9.17 results that is chi-squared
distributed with 8−5 = 3 degrees of freedom. Since there
cannot be heterogeneity between studies, in this example
Qinc and dfQinc are identical to Qnet and dfQnet .
If some of the component meta-analyses are het-
erogeneous, the others can still validly be tested by
their Qhetd . Even Qinc has some interpretation in this
case: The direct estimates are estimates of the inverse
variance-weighted averages of diﬀerent true but unknown
study-speciﬁc treatment eﬀects. Then, Qinc with the
same reference distribution provides a valid test of the
hypothesis of consistency of these averaged treatment
eﬀects.
Detaching a single design
Once inconsistency is indicated by a large Qinc, formula
(11) can be used to assess the contribution of each com-
ponent meta-analysis of design d to the inconsistency.
In fact, Qinc is the sum of quadratic forms of residuals
over all designs. For simple comparisons between two
treatments, the summands are squared Pearson residu-
als. Unfortunately, a deviating eﬀect of one component
meta-analysis can simultaneously inﬂate several residuals.
Therefore, we ﬁt a set of extended models allowing for
a deviating eﬀect of each study design in turn and recal-
culate the Q statistic. This procedure is equivalent to a
’leave one out’ approach: Once per ﬁt, studies with one
design are left out of the network estimate to obtain an
independent estimate of the treatment eﬀect in design d
and to obtain a network model ﬁt independent of stud-
ies with design d (for another leave one out approach,
see [14]).
More formally, we modify model (5) by inserting Nd − 1
new parameters θdir-indd into the parameter vector θnet(d) :=
(θnet, θdir-indd ) for all pairwise treatment comparisons in
design d to the design-speciﬁc reference. The design
matrix of the new model needs an extra column for
each new parameter, here notated as set of indicator
vectors 1{d}, with entry one for each pair-wise com-
parison in d and entry zero for all other comparisons.
So we add Nd − 1 columns for each design with Nd
treatments. Each additional column corresponds to one
of the non-reference-treatments. We have the following
model:
θˆdir = (Xa,1{d})θnet(d) + , (12)
with E() = 0 and Cov() = Va as previously. In
this model, the parameters θnet capture all network evi-
dence without the information from studies with design d,
and the parameters θdir-indd denote the diﬀerence between
direct and indirect eﬀect estimate in design d. The lat-
ter is called a design-by-treatment interaction in White
et al. [16], but in contrast to White et al., we only add
extra columns for one design at a time. Remaining incon-
sistency in this model can be tested by the corresponding
Q statistic:
Qinc(d) := R′(d)V−1a R(d) (13)
that is chi-squared distributed with dfQinc
(d)
degrees of free-
dom (see Table 1). Here, the vector
R(d) := θˆdir − (Xa,1{d})θˆnet(d) (14)




d=1(Nd − 1) contains the residuals that are
identical to those of a consistency model ﬁtted after hold-
ing out design d. And in the case of design d, the residuals
equal zero.
For illustration purposes, we successively introduce one
new parameter for each of the eight possible detachments
of one component meta-analysis into the inconsistent net-
work example from Section “Decomposition of Cochran’s
Q” corresponding to Figure 1. For design 1:2, we use
a parameter vector extended by θdir-ind1:2 in model (12);
in combination with the design matrix (Xa, (1, 0, . . . , 0)′).
With θˆnet(1:2) = (5, 0, . . . , 0)′ this results inQinc(1:2) = 0+· · ·+
0 = 0 that is chi-squared distributed with two degrees of
freedom. For design 1:3, we respectively obtain Qinc(1:3) =
1.15 + 0.00 + 1.15 + 1.15 + 1.15 + 0.13 + 0.50 + 0.13 =
5.36 that is also chi-squared distributed with two degrees
of freedom.
Finally, to locate the inconsistency in the network, we
compare the remaining inconsistency after exclusion of
design d studies to the inconsistency before exclusion for
all designs d′ = 1, · · · ,D by:
Qdiﬀd′,d := Qincd′ − Qincd′(d). (15)
Here,
Qincd′ := (θˆdird′ − Xd′ θˆnet)′V−1d′ (θˆdird′ − Xd′ θˆnet) (16)
is the summand in Qinc belonging to design d′ (it is∑D
d′=1Qincd′ = Qinc), and Qincd′(d) is the corresponding part
from Qinc
(d) and model (12). Since R(d)d′ = 0 for all d′ = d;
it follows that in this case Qdiﬀd′,d = Qincd′ . In other words,
Qdiﬀd′,d is the reduction of the squared standardized resid-
ual Qincd′ for design d′ due to elimination of design d
studies.
In the example, holding out design 1:2 results in a per-
fect ﬁt of model (12) and we obtain Qdiﬀd′,1:2 = Qincd′ for
all d′ in {1:2,...5:6} (Qdiﬀ1:2,1:2 = 3.36,Qdiﬀ1.3,1:2 = 1.78, . . . )
since Qincd′(1:2) = 0. For the detachment of the component
meta-analysis with design 1:3, we obtain Qdiﬀ1:2,1:3 = 2.21,
Qdiﬀ1:3,1:3 = 1.78, and so on.
The net heat plot
For a graphical inspection of network inconsistency,
we use a color visualization of the quadratic matrix
(Qdiﬀd′,d)d′,d=1,...,D, which we call a net heat plot in the fol-
lowing. Warm colors in this plot (yellow over orange
to red) indicate a positive Qdiﬀd′,d. A negative Qdiﬀd′,d is
illustrated by blue colors. Because of the non-negative









Figure 2 Network design of an illustrative network
meta-analysis. The nodes correspond to eight treatments and the
edges display observed treatment comparisons. Design 6:7 and 3:4
do not contribute to the inconsistency assessment and are not
incorporated into a net heat plot.
up to the Qinc statistic, the corresponding diagonal ele-
ments of the plot have non-blue colors. Warm colors on
the oﬀ-diagonal of the plot indicate that a detachment
of the component meta-analysis with design d (shown
in the columns) reduces the inconsistency at design d′
(shown in the rows). The inconsistency between direct
and indirect evidence at design d′ before the detach-
ment is indicated by the color of the diagonal element
d′. An increase in inconsistency is indicated by blue
colors. The stronger the intensity of the color is, the
greater the diﬀerence between the inconsistency before
and after the detachment of studies with design d is. The
color of the whole plot is implemented to have a max-
imum intensity for absolute values greater or equal to
eight.
Designs where only one treatment is involved in
other designs of the network (for example design 6:7
in Figure 2) or where the removal of Sd would lead
to a splitting of the network (for example design
3:4 in Figure 2) do not contribute to the inconsis-
tency assessment and are not incorporated into the net
heat plot.
For the arrangement of the rows and columns of the
plotted matrix, we use the sum of the absolute distances
between the rows and the absolute distances between
the columns of (Qdiﬀd′,d)d′,d=1,...,D for complete linkage
clustering (see for example [34]). This results in col-
ored block structures that potentially indicate hot spots
of inconsistency.
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In the plot we also draw gray squares, as shown in
Figure 1b), with areas proportional to the corresponding
absolute elements of the hat matrix from equation (6). The
larger the square is, the stronger the direct estimate of
design d drives the network estimate of design d′. Conse-
quently, a design d with large squared Pearson residuals
Qincd strongly inﬂuences design d′. The combination of
the color for the inconsistency and the diﬀerently-sized
squares results in the visual appearance of a halo that
relays both types of information at the same time (see
for example [35] for use of such halo visualizations in a
diﬀerent context).
Further illustrative examples
To illustrate the application of the net heat plot,
we consider the network example from the previous
sections and Figure 1 as well as four additional net-
work meta-analysis examples with six treatments and six,
eight, or all possible ﬁfteen component meta-analyses
based on two-armed studies (d in {1:2, 1:3, . . . , 5:6} with
Nd = 2). These networks are displayed as graphs in
Figures 3a) to e) on the left side, where the edges cor-
respond to the diﬀerent direct comparisons. The thick-
ness of an edge represents the inverse standard error






























































































































































































Figure 3 Five illustrative network meta-analyses with net heat plot. In a) to e), the network design is shown on the left: six treatments and six,
eight or ﬁfteen diﬀerent observed designs based on two-armed studies. The nodes are placed on the circumcircle and are labeled according to the
treatments. The edges show which treatments are directly compared. The thickness of an edge represents the inverse standard error (Vdird )
−1/2,
which is equal one for all designs. We introduced inconsistency by perturbing the eﬀect of one edge (marked in red) by ﬁve standard errors of the
direct eﬀect estimate. The corresponding net heat plots are shown on the right side: The area of the gray squares displays the contribution of the
direct estimate in design d (shown in the column) to the network estimate in design d′ (shown in the row). The colors are associated with the
change in inconsistency between direct and indirect evidence in design d′ (shown in the row) after detaching the eﬀect of design d (shown in the
column). Blue colors indicate an increase and warm colors indicate a decrease (the stronger the intensity of the color, the stronger the change).
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We have produced an inconsistent network of treat-
ment eﬀects by adding a δ = 5 to one treatment
eﬀect θdird , while all other eﬀects of the network remain
zero.
Because the network structures and the assumed pre-
cisions of the direct eﬀects are the same in scenar-
ios a) to c), they share the same hat matrix, which
is discussed in Section “Identifying drivers via the hat
matrix” and illustrated in Figure 1b). That is why
the net heat plots in Figures 3a) to c) contain the
same gray squares, just ordered diﬀerently due to
the clustering.
In scenario a), inconsistency is introduced through the
treatment eﬀect in design 1:2. The overall inconsistency
statistic is Qinc = 9.17 (p = 0.027, see Table 2). In
the net heat plot, the color intensities of the diagonal
elements indicate that the squared Pearson residual for
design 1:3 and especially the residuals for the designs
1:2 and 2:3 almost solely contribute to Qinc. The latter
ones have higher residuals, although their direct estimates
drive their network estimates more strongly, with 63%
in contrast to 53% in the case of design 1:3. This can
be seen in the hat matrix elements that are displayed
here by the area of the squares. The warm-colored oﬀ-
diagonal elements in the column of design 1:2 or 2:3 are
equal to the colors on the diagonal, which indicates a
complete elimination of inconsistency in the whole net-
work after relaxing design 1:2 or 2:3. This is also rec-
ognizable by Qinc(1:2) and Qinc(2:3) in Table 2, each with a
p value of one. A detachment of design 1:3 does not
reduce all residuals but increases that of the designs 1:6,
3:4, and 4:6, as indicated by the blue colors. Relaxing
other designs causes only little change to the squared
Pearson residuals. For example relaxing design 1:6 weakly
reduces the residuals of design 1:2 and 2:3 but inﬂates
the residuals of design 1:3 and increases the inconsis-
tency in the whole network (p = 0.016 for Qinc(1:6)). Due
to the arrangement of the rows and columns in the plot
(as explained in Section “The net heat plot”), we can
see a hot spot of inconsistency between the eﬀects of
the component meta-analyses with designs 1:2, 2:3, and
1:3 by the warm-colored block on the diagonal; how-
ever, the eﬀect of 1:3 is supported by other evidence of
the network shown by the blue-colored elements in row
and column of design 1:3. Altogether, designs 1:2 and 2:3
can be identiﬁed as a source of inconsistency in the net-
work. However, to be able to understand whether the
eﬀects of the component meta-analyses of both designs
are the source or whether only one of them is, we need
more network connectivity so that they are included
solely in network loops. The squares in the columns of
the two identiﬁed designs show that the corresponding
treatment eﬀects drive the network estimate of design
1:3, which is therefore perturbed. Although attenuated,
driving is also observed in designs 1:6, 3:4, and 4:6, as
far as the inﬂuence of the eﬀect in design 1:2 (and 2:3)
is suﬃcient.
In scenario b), we shifted the eﬀect in design 1:6 anal-
ogously to scenario a) by δ = 5 from the rest of the
network. This causes a Qinc of only 7.50 with a p =
0.058, which is mainly composed of the squared Pearson
residuals of designs 1:3 and 4:6 and especially of the
residuals of designs 1:6 and 3:4. Contrasting the colors
and the size of squares on the matrix diagonal shows
that the latter two hold the strongest inconsistency con-
tribution, although their corresponding direct estimates
drive their network estimates the most strongly. In this
scenario, a detachment of the eﬀect in designs 1:6 or
3:4 eliminates the inconsistency of the network. In con-
trast, relaxing one of the designs 1:2, 2:3, 4:5, or 5:6
only slightly reduces the inconsistency of the whole net-
work (each Qinc(1:2), Qinc(2:3), Qinc(4:5), Qinc(5:6) with p = 0.033),
and a detachment of designs 1:3 or 4:6 even increases
the inconsistency (each Qinc(1:3), Qinc(4:6) with a p = 0.033).
As well, in all six cases the squared Pearson residual
of at least one other design is inﬂated. So in this sce-
nario, we see a hot spot of inconsistency between designs
1:6, 3:4, 1:3, and 4:6 by the intense warm-colored block
on the diagonal (4 × 4). The strongest inconsistency is
between the eﬀect in designs 1:6 and 3:4.Weaker inconsis-
tency can be observed between the eﬀects in the designs
1:2 and 2:3 as well between the eﬀects in 4:5 and 5:6.
The eﬀects of designs 1:3 and 4:6 are supported by the
evidence of the designs 1:2 and 2:3 as well as 4:5 and
5:6 respectively. So in this scenario, designs 1:6 and 3:4
can be identiﬁed as a plausible source of inconsistency,
and analogous to scenario a), the inconsistency caus-
ing edge 1:6 cannot be distinguished from the jointly-
acting edges 3:4, although in this example these two
are not adjacent edges. The squared Pearson residuals
for the two identiﬁed designs, shown on the diagonal
of the plot, are smaller in comparison to the residuals
of the designs 1:2 and 2:3 in scenario a), although in
both scenarios a perturbation is introduced with δ = 5.
This is because the corresponding network estimates are
more strongly driven by their direct estimates with each
70% and not only with 63% as in designs 1:2 and 2:3.
The squares in the columns of the two identiﬁed designs
indicate that they drive the network estimates in designs
1:3 and 4:6 and, a little weaker, of the remaining other
designs, which therefore diﬀer from their direct estimates.
Contrasting the colors and the size of squares on the oﬀ-
diagonal elements of all 2 × 2 blocks on the diagonal
implies that the weakest amount of treatment eﬀect devi-
ation is observed between the eﬀects in designs 1:2 and
2:3 as well as between the eﬀects in 4:5 and 5:6, since
the largest hat matrix elements are here as well the less
intensive color. Altogether, the inﬂuence of the perturbed
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Table 2 The inconsistency in the illustrative examples
a) b) c) d) e)
Q df p Q df p Q df p Q df p Q df p
Qinc 9.17 3 0.027 7.50 3 0.058 11.67 3 0.009 4.17 1 0.041 16.67 10 0.082
Qinc(1:2) 0.00 2 1 6.82 2 0.033 6.82 2 0.033 0.00 0 1 0.00 9 1
Qinc(1:3) 5.36 2 0.069 5.36 2 0.069 0.00 2 1 15.62 9 0.075
Qinc(1:4) 15.62 9 0.075
Qinc(1:5) 15.62 9 0.075
Qinc(1:6) 8.33 2 0.016 0.00 2 1 8.33 2 0.016 0.00 0 1 15.62 9 0.075
Qinc(2:3) 0.00 2 1 6.82 2 0.033 6.82 2 0.033 0.00 0 1 15.62 9 0.075
Qinc(2:4) 15.62 9 0.075
Qinc(2:5) 15.62 9 0.075
Qinc(2:6) 15.62 9 0.075
Qinc(3:4) 8.33 2 0.016 0.00 2 1 8.33 2 0.016 0.00 0 1 16.67 9 0.054
Qinc(3:5) 16.67 9 0.054
Qinc(3:6) 16.67 9 0.054
Qinc(4:5) 9.09 2 0.011 6.82 2 0.033 11.36 2 0.003 0.00 0 1 16.67 9 0.054
Qinc(4:6) 8.93 2 0.012 5.36 2 0.069 10.71 2 0.005 16.67 9 0.054
Qinc(5:6) 9.09 2 0.011 6.82 2 0.033 11.36 2 0.003 0.00 0 1 16.67 9 0.054
The Q statistic for inconsistency as well the Q statistic after detaching the eﬀect of design d are given for each of the scenarios a) to e) in Figure 3. In addition, the
degrees of freedom (df) of the corresponding chi-squared distribution and the p value (p) are shown.
treatment eﬀect in design 1:6 is more broad, but with
overall weaker severity as the equally perturbed eﬀect in
scenario a).
In scenario c), we changed the eﬀect in design 1:3
with δ = 5 and found the highest network inconsis-
tency statistic Qinc = 11.67 (p = 0.009) in comparison
to both previous scenarios. The squared Pearson resid-
ual for design 1:3 provides the largest contribution to
the Qinc statistic. Smaller residuals are observed for the
adjacent edges 1:2, 2:3, 1:6, and 3:4. A detachment of
the eﬀect in design 1:3 eliminates the inconsistency of
the network. Relaxing other designs causes only a little
change to the squared Pearson residuals and increases
residuals for some designs. A hot spot of inconsistency
can be seen between the eﬀects in designs 1:3, 1:2, and
2:3. However, the eﬀect in design 1:2 is supported by the
eﬀects in designs 1:6, 3:4, and 4:6, and vice versa, the lat-
ter ones are supported by the eﬀects in design 1:2. The
same holds for the eﬀect in design 2:3 and the eﬀects
in the three designs. Altogether, edge 1:3 can be dis-
tinctly identiﬁed as a plausible source of inconsistency
since this is nested in two loops. The squared Pear-
son residual for this design is higher in comparison to
the residuals for the inconsistency-generating designs in
the previous two scenarios, although in all scenarios an
equally strong perturbation is introduced. This is because
1:3 is the least self-driving design. Since the eﬀect of
design 1:3 strongly drives the network estimates of the
designs 1:2, 2:3, 1:6, and 3:4, they are also inﬂuenced by
the perturbation.
In scenario d), we analyze a sparsely connected network
that forms one loop. In such a network with observed
inverse standard errors being the same for each direct esti-
mate, all corresponding network estimates are composed
83% of its own and 17% balanced of all other direct esti-
mates. So, in the net heat plot we see only large squares
on the diagonal. A perturbation of the eﬀect at design 1:2
results in a network inconsistency statistic of Qinc = 4.17
(p = 0.041), which is the sum of equally-sized squared
Pearson residuals. A detachment of any design interrupts
the loop and ﬂow of evidence so that the network esti-
mates correspond, if existing, to their direct estimates and
the inconsistency of the network is dissolved. In this sce-
nario, we can recognize inconsistency but cannot locate
its source since we have insuﬃcient degrees of freedom.
Nevertheless, several indirect estimates were aﬀected by
the perturbation of design 1:2.
In network scenario e), all ﬁfteen possible pairwise com-
parisons are observed with same precision. Because of this
tight linkage, each network estimate is driven one-third
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by its corresponding direct estimate. The remaining two-
thirds of indirect estimation is based on all eight adjacent
edges in a balanced way. The disturbance of the network
consistency by adding a δ = 5 to treatment eﬀect θdir1:2
does not produce as much inconsistency in the whole net-
work as seen in the other scenarios (Qinc = 16.67 with
p = 0.082). Almost exclusively, the squared Pearson resid-
ual for design 1:2 is increased so that a detachment of
design 1:2 eliminates the inconsistency. A detachment of
one of the eight adjacent edges causes only a little change
and even weakly increases the inconsistency in the whole
network, which results each time in a p value of 0.075. In
the case of non-adjacent edges, the p values correspond-
ing toQinc
(d) are even 0.054. So in this scenario, the source of
inconsistency is uniquely identiﬁable in the net heat plot,
even more easily compared to scenario c). It only weakly
drives and aﬀects the network estimates of its adjacent
edges so that the perturbation of the eﬀect in design 1:2
has only a little inﬂuence on the network.
The examples show that perturbation of a single design
may have side eﬀects on residuals, more or less spread
out in the network. Our clustering proved successful in
grouping together designs with interrelated residuals that
were simultaneously aﬀected by one perturbation. The
resulting hot spots facilitate the identiﬁcation of sources of
inconsistency, which may or may not be uniquely identi-
ﬁable. While related large residuals are obviously grouped
together, it may also occur that large residuals emerg-
ing from two independent perturbations are also grouped
in proximity. In this case we expect to ﬁnd two diago-
nal blocks, each signaling the local side eﬀects of one
perturbation and each representing one hot spot of incon-
sistency.
Software
We implemented our methods in the open-source statisti-
cal environment R [36]. While multivariate meta-analysis
for the aggregation step of studies with the same design
can be carried out using standard statistic software
[28,37], we provide a preliminary stand-alone R func-
tion for the net heat plot available on the website http://
www.unimedizin-mainz.de/ﬁleadmin/kliniken/imbei/
Dokumente/Biometrie/Software/netheat.R. An R package
is in preparation and will be available from the standard
CRAN repository for the R environment.
Results
An example of a network meta-analysis in diabetes
We applied our methods to a network meta-analysis
example by Senn at al. [17]. They examined the con-
tinuous outcome of blood glucose change according
to the marker HbA1c in patients with type two dia-
betes after adding one treatment out of ten diﬀer-
ent groups of glucose-lowering agents to a baseline
Figure 4 Network design in the diabetes example. The nodes are
placed on the circumcircle and are labeled according to the
treatments. The edges display the observed treatment comparisons.
The thickness of the edges is proportional to the inverse standard
error of the treatment eﬀects, aggregated over all studies including
the two respective treatments. The network includes 25 two-armed
studies on fourteen diﬀerent designs and one three-armed study of
design plac:acar:metf.
sulfonylurea therapy. As eﬀect measures, we consider
mean diﬀerences.
The ten diﬀerent treatment groups are abbreviated
as follows by their ﬁrst four letters: acar: Acarbose,
benf: Benﬂuorex, metf: Metformin, migl: Miglitol, plac:
Placebo, piog: Pioglitazone, rosi: Rosiglitazone, sita:
Sitagliptin, SUal: Sulfonylurea alone, vild: Vildagliptin.
This network meta-analysis involved 26 randomized
controlled trials including one three-armed trial for
plac:acar:metf and 15 diﬀerent designs, of which ten are
used in only one study. In the network, 15 out of 45 pos-
sible diﬀerent pair-wise contrasts are observed, of which
eight involve a placebo (see Figure 4).
Across the entire network (analogues to the result of
Senn at al. [17]) as well as for exclusively within designs,
we observed heterogeneity with p values < 0.001 (see
Table 3). Regarding the Qhetd statistics, the component
meta-analyses with designs plac:benf, plac:metf, plac:migl,
and, plac:rosi contribute the most to the heterogeneity
within designs.
To have a closer look at the inconsistency of the net-
work, we use the net heat plot in Figure 5. Studies with
design plac:benf, plac:migl, plac:sita, or plac:vild are not
included in this plot because they do not contribute to
the inconsistency assessment. There are direct treatment
eﬀects that strongly drive other network estimates in a
consistent manner. For example, the treatment eﬀects
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Table 3 Heterogeneity and inconsistency in the diabetes example
Q statistic Number of studies Degrees of freedom p value
Qnet 96.98 26 27-9=18 < 0.001
Qinc 22.53 26 16-9=7 0.002
Qhet 74.45 26 27-16=11 < 0.001
Qhetplac:benf 4.38 2 2-1=1 0.036
Qhetplac:metf 42.16 3 3-1=2 < 0.001
Qhetplac:migl 6.45 3 3-1=2 0.040
Qhetplac:rosi 21.27 6 6-1=5 0.001
Qhetmetf:rosi 0.19 2 2-1=1 0.665
The decomposition of the Q statistics as well as the degrees of freedom of the corresponding chi-squared distributions and the p values are shown. In addition the
considered number of studies are displayed. Only one study is observed for the following designs: plac:acar, plac:piog, plac:sita, plac:vild, acar:SUal, metf:piog,
metf:SUal, piog:rosi, rosi:SUal, plac:acar:metf. For this reason, the corresponding Qhetd statistics are not shown.
in designs plac:acar and acar:SUal agree with the exist-
ing direct evidence of each other, but we observe a Qinc
statistic with a p value of 0.002, which is composed of
the squared Pearson residuals for the designs metf:SUal,
rosi:SUal, plac:piog, metf:piog, and plac:rosi. The ﬁrst two
have higher residuals in comparison to plac:piog, although
their direct estimates more strongly drive their network
estimates, with 56% and 41% in contrast to 36% in the
case of design plac:piog. We can observe a hot spot of
inconsistency between the eﬀects in designs metf:SUal,
rosi:SUal, plac:piog, and metf:piog, for which only one
study is observed in each case. The eﬀects in designs
plac:piog and metf:piog as well as, in particular, the
designs metf:SUal and rosi:SUal are especially inconsis-
tent. Although the direct estimate in design plac:rosi is
hampered with large heterogeneity (p = 0.001), it has
a large evidence base of six studies and hence strongly
















































































Figure 5 Net heat plot in the diabetes example. The area of the gray squares displays the contribution of the direct estimate in design d (shown
in the column) to the network estimate in design d′ (shown in the row). The colors are associated with the change in inconsistency between direct
and indirect evidence in design d′ (shown in the row) after detaching the eﬀect of design d (shown in the column). Blue colors indicate an increase
and warm colors indicate a decrease (the stronger the intensity of the color, the stronger the change). The two contrasts of the three-armed study
with design plac:acar:metf are marked with ∗ .












































































Figure 6 Net heat plot in the diabetes example after exclusion of the study with design rosi:SUal. The area of the gray squares displays the
contribution of the direct estimate in design d (shown in the column) to the network estimate in design d′ (shown in the row). The colors are
associated with the change in inconsistency between direct and indirect evidence in design d′ (shown in the row) after detaching the eﬀect of
design d (shown in the column). Blue colors indicate an increase and warm colors indicate a decrease (the stronger the intensity of the color, the
stronger the change). The two contrasts of the three-armed study with design plac:acar:metf are marked with ∗ .
estimates as well. Note, that the contribution of single
studies is easily disclosed by splitting the amount of 83%
into a sum according to the inverse variances of the esti-
mates of each study (83% = 11% + 18% + 20% + 22% +
4% + 8%). A detachment of the corresponding design
reduces the residuals of design metf:SUal, rosi:SUal, and
plac:piog, but inﬂates the residuals of design metf:rosi and
piog:rosi. Overall, a detachment of the eﬀects for each
of the ﬁve inconsistent component meta-analyses men-
tioned increases the squared Pearson residuals for some
other designs in the network and results in blue entries in
the plot.
The strongest reduction in the whole network incon-
sistency is achieved with a detachment of the eﬀect
in design rosi:SUal. In this case, the net heat plot in
Figure 6 results. The inconsistency between the eﬀects
in designs plac:piog and metf:piog remains, but in an
attenuated form. Now, the eﬀect of design metf:SUal
is inconsistent with the eﬀect of the designs plac:acar
and acar:SUal, which were supported by the eﬀect in
design rosi:SUal in the previous version of the network.
However, with a p value of 0.342 for the Qinc statistic,
there is no longer strong evidence for inconsistency. The
hot spot of inconsistency detected included designs with
only one study. Indeed, one or a few biased studies may
either cause heterogeneity when paralleled by other stud-
ies of the same design (which is observed within the
plac:rosi studies) or may cause inconsistency when solely
representing a design.
An example of a network meta-analysis in antidepressants
Cipriani et al. [12] performed a network meta-analysis
to examine the eﬃcacy between twelve new-generation
antidepressants as monotherapy for the acute-phase treat-
ment of major depression. The twelve antidepressants are
abbreviated as follows: bupr: Bupropion, cita: Citalopram,
dulo: Duloxetine, esci: Escitalopram, ﬂuo: Fluoxetine, ﬂuv:
Fluvoxamine, miln: Milnacipran, mirt: Mirtazapine, paro:
Paroxetine, rebo: Reboxetine, sert: Sertraline, venl: Ven-
lafaxine. The eﬃcacy was deﬁned as a reduction of at
least 50% from the baseline depression rating score after 8
weeks. For the network meta-analysis, they involved 111
randomized controlled trials including two three-armed
trials of design ﬂuo:paro:sert. In these studies, 42 of 66
possible pair-wise contrasts between the 12 treatments are
observed (see Figure 7) in D = 43 diﬀerent designs, of
which 16 are observed in only one study.
Analogous to [12], we used log odds ratios as eﬀect
measures, but for combining study estimates we used the
ﬁxed-eﬀects model (5) instead of a random-eﬀects model
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Figure 7 Network design in the antidepressants example. The
nodes are placed on the circumcircle and are labeled according to
the treatments. The edges display the observed treatment
comparisons. The thickness of the lines is proportional to the inverse
standard error of the treatment eﬀect, aggregated over all studies
including these two respective treatments. The network includes 109
two-armed studies with 42 diﬀerent designs and two three-armed
studies, both with design ﬂuo:paro:sert.
within the Bayesian framework. The treatment eﬀects and
respective standard errors of our model are very simi-
lar to the results of Cipriani et al. [12], and the standard
errors are not systematically smaller as could be expected,
because we observed only little heterogeneity in the whole
network (p = 0.113) as well as within designs (p = 0.125)
and no signiﬁcant inconsistency (p = 0.293). This results
from the calculated Q statistics corresponding to Section
“Decomposition of Cochran’s Q” (see Table 4). Regarding
the heterogeneity within the designs, only the two studies
with design paro:sert are conspicuous, with a p value of
0.006.
The net heat plot presented in Figure 8 provides a
detailed assessment of the slight inconsistency in this
quite tightly connected network. As seen from the color
on the diagonal of the plot, the squared Pearson residu-
als for designs cita:esci, cita:paro, ﬂuo:bupr, and mirt:venl
contribute the most to Qinc. There is a small hot spot
of inconsistency between the eﬀects in designs cita:esci
and cita:paro as well as between the eﬀects in ﬂuo:bupr
and bupr:sert. The largest squared Pearson residual is
observed for design cita:esci, although the direct esti-
mate in this design drives the corresponding network
estimate comparatively strongly with 51% (maximum self-
driving is observed in design dulo:esci with 61%). In
contrast to the other four designs mentioned, the direct
estimate of cita:esci also strongly drives network esti-
mates for some other designs in the network, which can
be seen from the square sizes in the corresponding col-
umn. A detachment of the eﬀect in design cita:esci results
in the strongest reduction of the inconsistency in the
whole network (resulting in Qinc(cita:esci) = 29.6 with p =
0.591). While the direct evidence contributes more than
50% of the network estimate of this contrast, the direct
estimate is larger than the network estimate (log odds
ratio 0.39 vs. 0.17), and publication bias may be aﬀect-
ing the former one. The squared Pearson residuals for
the designs cita:paro, cita:mirt, esci:paro, and esci:sert
are particularly reduced. In contrast, the direct treatment
eﬀects of designs ﬂuo:venl and ﬂuo:paro have the small-
est standard error and drive the network estimates of
many other designs (see large squares in the correspond-
ing columns in Figure 8); however, a detachment of one
of these designs causes only small changes in the squared
Pearson residuals.
Discussion
To ensure the validity and robustness of the conclu-
sion from a network meta-analysis, it is important to
assess the consistency of the network and the contribu-
tion of each component meta-analysis to the estimates.
Our intention was to develop a sensitivity analysis tool
that allows the identiﬁcation of which component meta-
analyses drive which network estimates and to locate the
drivers that may have generated a hot spot of inconsis-
tency. The net heat plot serves both purposes simulta-
neously: the ﬁrst one by graphically showing elements
of the hat matrix and the latter one by colored block
structures in the plot. We have shown that the net heat
plot allows the identiﬁcation of a single deviating design
that induces inconsistency in artiﬁcial examples. In the
case of stronger network connectivity, increased loca-
tion speciﬁcity might be possible. In networks that only
include one loop, it is not possible to trace inconsis-
tency back to a single design, but designs that are part
of several loops may be identiﬁable as a unique source
for a hot spot of inconsistency. We also demonstrated
the applicability of the plot in two published network
meta-analyses.
It is well known in regression diagnostics (see for
example [29]) that the inﬂuence of an observation
(on parameter estimates and prediction) is driven by both
the respective residual and the diagonal element of the
hat matrix. Analogous to classical meta-analyses, outlier
eﬀect estimates of single studies or a few highly-weighted
studies play an important role, which can be inspected
in forest plots. Inﬂuence measures are usually displayed
as index plots with observation numbers on the horizon-
tal axis; this has been successfully exploited for simple
meta-analysis [21,22]. We felt that this is insuﬃcient in
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Table 4 Heterogeneity and inconsistency in the antidepressants example
Q statistic Number of studies Degrees of freedom p value
Qnet 119.6 111 113-11=102 0.113
Qinc 36.9 111 44-11=33 0.293
Qhet 82.7 111 113-44=69 0.125
The Q statistic for the whole network, for inconsistency and for heterogeneity within designs are shown. In addition, the number of studies on which they are based,
the degrees of freedom of the corresponding chi-squared distributions and the corresponding p values are displayed.
network meta-analyses and thus proposed the net heat
plot as an additional tool. We display all elements of
the hat matrix in the net heat plot and pointed out
that the lines of the hat matrix are the linear coeﬃ-
cients for a speciﬁc network estimate. As such they rep-
resent the natural generalization of simple meta-analysis
weights. They quantify the contribution of a component
meta-analysis to the network-estimate of a given contrast
and may therefore be of interest, even in a consistent
network meta-analysis. Simultaneously, the changes in
the squared Pearson residuals are visualized in the net
heat plot after allowing for a deviating eﬀect of one sin-
gle component meta-analyses to detect outlying direct
estimates. In passing, we have shown that Cochran’s chi-
squared statistic, the sum of squared Pearson residuals,
can be generally used in network meta-analyses in a ﬁxed-
eﬀects model framework to assess the heterogeneity of































































































































































































































































Figure 8 Net heat plot in the antidepressants example. The area of the gray squares displays the contribution of the direct estimate in design d
(shown in the column) to the network estimate in design d′ (shown in the row). The colors are associated with the change in inconsistency between
direct and indirect evidence in design d′ (shown in the row) after detaching the eﬀect of design d (shown in the column). Blue colors indicate an
increase and warm colors indicate a decrease (the stronger the intensity of the color, the stronger the change). The two contrasts of the two
three-armed trials with design ﬂuo:paro:sert are marked with ∗ .
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out the inconsistency of the network. Particularly, we
have shown howmulti-armed studies can be incorporated
both into the inconsistency chi-squared statistic via a
quadratic form of Pearson residuals and into the net
heat plot.
Overall, inconsistency testing has also been discussed
in large complex networks by comparing a consis-
tency model with an unrestricted inconsistency model
[10], as we have done in turn for each single compo-
nent meta-analysis. However, the authors essentially only
consider inconsistency between two-armed component
meta-analyses because they do not analyze independent
eﬀects for multi-armed studies. We included multi-armed
studies and thereby opened a way for dividing over-
all heterogeneity exhaustively into heterogeneity within
designs and inconsistency. Within a Bayesian framework,
the authors discuss models with and without a random
component for heterogeneity within component meta-
analyses.We advocate the ﬁxed-eﬀectsmodel, not only for
the sake of simplicity but, more importantly in the diag-
nostic framework, because it potentially provides a clearer
picture and allows for better recognition and location
of inconsistency. In contrast to testing loops for incon-
sistency [6], which leads to redundant testing of many
dependent hypotheses or is conﬁned to simple networks
composed of independent loops (as argued in [10]), our
approach is applicable in large and complex networks. The
approaches that capture inconsistency by a single extra
variance component in a mixed eﬀects model [8,9] only
aim at quantifying inconsistency and at providing conser-
vative conﬁdence intervals. The assumptions are diﬃcult
to justify or falsify and, more importantly, the approach
contains no straightforward way to locate inconsistency.
The recently published design-by-treatment interaction
model by [15,16] is most similar in spirit to our approach.
In contrast to White et al. [16] and Higgins et al. [15],
we do not include random eﬀects for heterogeneity within
designs. The advantage is that one or a few deviating or
biased studies are treated equally, whether they are par-
alleled by many other studies of the same design or are
the sole representative of their design. In a random-eﬀects
model, the former studies would add to the heterogene-
ity variance whereas the latter studies would inform ﬁxed
design-by-treatment interaction parameters. In a ﬁxed-
eﬀects model, inconsistency is indicated by the Q statistic
more sensitively than in the random-eﬀects model of
[16]. If heterogeneity or inconsistency is detected and not
explained by single outliers, the model should be extended
with study level covariates, along the lines explored by
[6,38]. Ideally we should end up with a homogeneous
model, thereby explaining rather than modeling hetero-
geneity and inconsistency.
However, the fact that failure to detect heterogene-
ity does not constitute proof of homogeneity must be
taken into account in the assessment of inconsistencies
in network meta-analyses. This already holds for a simple
meta-analysis and is even more relevant for network
meta-analyses. In a network without loops, inconsistency
cannot be detected at all. In this context, we point to the
importance of the hat matrix. It allows for the assessment
of the contribution of each component meta-analysis to
a network estimate and directs attention to the crucial
components. We have illustrated that often only a few
components are important.
Often, when inconsistency is observed, some compo-
nent meta-analyses are heterogeneous, too. We point out
that the inconsistency assessment is still valid in this con-
text. However, then the direct eﬀect estimates are no
longer estimates of a single parameter, but are rather
weighted averages of estimates of diﬀerent parameters:
the study-speciﬁc treatment eﬀects. Nevertheless, incon-
sistency assessment and the investigation of heterogeneity
within component meta-analyses may interfere in this
case, and it may be necessary to exclude single studies and
repeat the net heat plot in order to ﬁnd satisfactory expla-
nations of overall heterogeneity. In fact, inspection of both
coeﬃcients (entries of the hat matrix) and of residuals was
proposed by Senn et. al [17] at the study level, and this
may be more appropriate if heterogeneity within designs
is large. However, when applied at the study level, the net
heat plot also has the additional advantage of pointing to
inﬂuential studies, i.e. studies with large weight and large
residuals.
Heterogeneity and inconsistency can be broadly viewed
as diﬀerent aspects of heterogeneity, the latter being
understood as any discrepancy between results of single
studies and predictions based on a consistency model for
a network. This fact is not only reﬂected in the decompo-
sition of the Q statistic, but also underlines that our tools
can be applied either at an aggregate level or at a study
level. We presented the aggregate level approach here for
its parsimony. The study level approach may be more
appropriate, particularly if component meta-analyses are
strongly heterogeneous. In fact, a visual display of the hat
matrix at study level has been proposed and discussed
in [17]. Another potentially viable approach would be to
complement our tools at an aggregate level with ordinary
forest plots for component meta-analyses.
Some caution is due when interpreting a net heat
plot. Diﬀerent from usual regression diagnostics, a sin-
gle component meta-analysis may stand for a large body
of evidence in network meta-analyses. If a component
meta-analysis is recognized as deviating from the rest or
is identiﬁed as a major source of heterogeneity, it may or
may not provide the more reliable part of the whole body
of evidence. Song et al. [39] argued that sometimes the
indirect part of evidence may be more reliable than the
direct part. That is why tracking heterogeneity should only
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be the starting point for focusing on subject matter details
of component meta-analyses and, hopefully, single studies
for ﬁnding subject matter reasons for the observed het-
erogeneity, as argued by [40] for classical meta-analyses.
In fact, this process of investigation was demonstrated in
one example without using a formal tool to sort out incon-
sistency; this was a simple inspection of squared Pearson
residuals [17] and has been elaborated upon in worked
examples (e.g. in [38,41]). In large and complex networks,
we feel that the two step approach, separately investi-
gating inconsistency and heterogeneity within designs is
necessary in order to limit eﬀorts. Furthermore it speciﬁ-
cally can answer whether a set of studies sharing the same
design is inﬂuential.
More than in classical regression diagnostics, there are
model diagnostic challenges in network meta-analyses:
Masking, a phenomenon already known, may be more
pronounced here because we have inherently small
numbers of observations: the component meta-analyses.
Masking may occur if more than one observation devi-
ates from the true model. In this case, parameter esti-
mates are aﬀected by outliers even after holding out one
observation, and outliers may be obscured, i.e. masked
[29]. To tackle this, we combined the technique of with-
holding one observation with a graphical display. While
this is clearly adequate if only one outlier exists, it may
also facilitate the detection of more outliers. For a more
rigorous approach, methods of holding out several obser-
vations will have to be explored. The second problem,
uniqueness, is particularly virulent in network meta-
analyses: several component meta-analyses could be the
explanation for all observed inconsistency. We discussed
the extreme case of a circular network where inconsis-
tency is completely unidentiﬁable. The ability to track
down inconsistency to only one or at least a few com-
ponent meta-analyses depends, as we illustrated, on the
connectedness of the network. A lack of network con-
nectivity can be useful for planning further studies, but
the challenges for future research are twofold: ﬁnd rules
for the identiﬁability of deviating components and to
ﬁnd tools for economically displaying the ambiguity if it
exists.
Searching for inﬂuential component meta-analyses or
inﬂuential studies is not the only way for responding to
inconsistency and heterogeneity. As mentioned in [16]
and worked out in [38], the consistency model can be
extended to allow for (treatment by covariate interaction
of) study level covariates, and the model extension can
explain inconsistency and heterogeneity. Both approaches
are complementary. Of note, the net heat plot could again
be applied to an extended consistency model.
One core component of our approach is to allow com-
ponent meta-analyses to have deviating treatment eﬀects.
This idea of extending the model by relaxing parameter
constraints is easily extended to generalized linear models
for binary outcomes as well as to random-eﬀects models.
The approach is not conﬁned to withholding the eﬀects
of one design, but is naturally applicable to allowing for
an arbitrary number of designs to have speciﬁc deviat-
ing eﬀects, e.g. all designs containing a speciﬁc treatment.
In all types of generalization, the challenge remains to
perform these model relaxations in a systematic way and
to provide tools to transparently display the multitude of
results, for which our presented net heat can be a useful
starting point.
Conclusions
We have illustrated the importance of assessing consis-
tency in network meta-analyses, where, for example, one
deviating component meta-analysis may induce a hot spot
of inconsistency. As a tool for this task, we have devel-
oped the net heat plot that displays drivers of the network
estimates, plausible sources for inconsistency, and possi-
ble disturbed network estimates, illustrating its usefulness
in several artiﬁcial and real data examples.
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